The European Medicines Agency recommends fewer new substances than the US, but continues to see rapid approvals and a significant focus on hormonal disorders.
发布者:BY ALBERT RONNING-ANDERSSON,转转请注明出处:https://robotalks.cn/ema-lags-behind-fda-in-new-drugs-but-overall-activity-level-is-close-to-record-high/